Patients with DFS had a higher frequency of hypertension (76% vs 70%) and dyslipidaemia (72% vs 38%), and a higher use of Ace inhibitors/Angiotensin receptor blockers (ARBs) (46% vs 15%) and Statins (68% vs 50%) compared to healthy controls. This evidence concerns the gene ACE and inherited lipid metabolism disorder.